6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      MicroRNAs as circulating biomarkers in acute coronary syndromes: A review

      , , , , ,
      Vascular Pharmacology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Coronary artery disease (CAD) and its complications remain the most common cause of death worldwide. Cardiac troponins (cTn) are standard biomarkers used today for diagnosis and risk stratification of myocardial infarction (MI). Increasing efforts are made to develop additional, new biomarkers for more effective and safe rule-in and rule-out of MI patients at the emergency department. During the past decade, microRNAs (miRNAs) have emerged as new, potential diagnostic biomarkers in several diseases, including MI. In this review, we aimed to summarize some of the prominent studies in the field, and discuss the potential value of miRNAs in the diagnosis of MI.

          Related collections

          Author and article information

          Journal
          Vascular Pharmacology
          Vascular Pharmacology
          Elsevier BV
          15371891
          June 2016
          June 2016
          : 81
          : 15-21
          Article
          10.1016/j.vph.2016.04.001
          27084396
          14cbfca0-96e7-4c45-a61e-0b94c4aeb530
          © 2016

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article